Gritstone Oncology is a personalized cancer immunotherapy company that is advancing the field of immuno-oncology to fight cancer in patients with the most difficult-to-treat tumors. They develop potent, next-generation, personalized immunotherapies that harness the power of the patient’s own immune system to specifically recognize non-self targets displayed by the tumor (called tumor-specific neoantigens) to effectively destroy tumor cells.
Gritstone Oncology
